The Effect of Evening Primrose Oil on Clinical Symptoms in Women with Polycystic Ovary Syndrome
- Conditions
- Polycystic Ovary Syndrome (PCOS).Polycystic ovarian syndromeE28.2
- Registration Number
- IRCT20120718010324N73
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 62
Confirmation of the diagnosis of PCOS according to the criteria of the Androgen Excess/PCOS Society, including anovulation, chronic low ovulation, or polycystic ovaries and clinical or biochemical signs of hyperandrogenism
Minimum hirsutism score of 6 with the Freeman Galloway criterion
Having literacy to complete the questionnaires
BMI between 18.5 and 40
Ages 18-45 years
Not taking vitamins, minerals and omega-6 in the three months before the intervention
Having other androgenic disorders such as adrenal hyperplasia or androgen-producing tumor
Having Cushing's syndrome
Having thyroid gland diseases
Pregnancy or breastfeeding
Women undergoing infertility treatment at the time of the study
Previous surgery on one or both ovaries
Consumption of dietary supplements
Smoking and alcohol consumption
Occurrence of unfortunate events
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hirsutism score. Timepoint: Before the intervention and after the end of intervention. Method of measurement: Ferriman – Gallwey index.;Depression symptoms score. Timepoint: Before the intervention and after the end of intervention. Method of measurement: Beck Depression Inventory.
- Secondary Outcome Measures
Name Time Method Frequency of adverse events in the study groups. Timepoint: During the intervention. Method of measurement: Researcher-made checklist.;Anthropometric indices (waist circumference, hip circumference, BMI). Timepoint: Before and after the intervention. Method of measurement: Checklist of anthropometric indices.;Menstrual disorders. Timepoint: Before and after the intervention. Method of measurement: Menstrual characteristics questionnaire.